Abstract

Mark Parrino, founder and President of the American Association for the Treatment of Opioid Dependence (AATOD), highlighted some of the reasons for the current outlook on opioid treatment programs (OTPs) – which for a few months or years, depending on your perspective, has not been great. The main reason is the American Society of Addiction Medicine (ASAM), which used to be a solid partner of AATOD and OTPs (see https://onlinelibrary.wiley.com/doi/10.1002/adaw.30330), but which in recent years has had a change in leadership and advocacy. What ASAM wants now is for MOTAA to pass – a bill which would allow ASAM‐certified physicians to prescribe methadone for opioid use disorder (OUD) to their patients. Under current federal law and regulation, only federally certified OTPs can provide (prescribe and dispense) methadone, and they do a lot more than just provide the medication.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call